The global effort to change the name of PCOS to PMOS might make GLP-1 weight loss drugs more accessible to women.

Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ...

A single enzyme inside liver cells drives the production of triglycerides that, in excess, fuel the inflammation and scarring ...

A promising new drug may offer fresh hope to millions of people living with one of the fastest-growing liver diseases in the world. Researchers at the University of California San Diego School of ...

A serious liver disease that affects millions of people around the world may soon have a powerful new treatment option. Researchers at the University of California San Diego have developed a drug that ...

Enhanced, abbreviated MRI (AMRI) outperformed ultrasonography (US) as a screen for early liver cancer in high-risk patients with cirrhosis, according to a single-center, randomized clinical trial.

Combination tobevibart 300 mg + elebsiran 200 mg q4w achieved HDV RNA TND in 77% at week 72 and 88% at week 96, outperforming tobevibart monotherapy. Profound HBsAg lowering occurred with dual therapy ...

A liver transplant is now potentially the only curative treatment option for Flo, 31, but she is unable to get the operation on the NHS ...

Groundbreaking advancements in hepatitis B research were published this week as a study in The New England Journal of Medicine found a potential cure for the chronic disease, which has thus far been ...

ORLANDO, FL / ACCESS Newswire / May 29, 2026 / RedChip Companies will air interviews with Foremost Clean Energy Ltd.

Researchers have identified metabolic vulnerabilities in Fibrolamellar cancer, a rare liver malignancy affecting adolescents and young adults, using functional profiling and mass spectrometry. The ...